Azenta, Inc. (AZTA)
38.75
+4.27
(+12.38%)
USD |
NASDAQ |
Oct 02, 16:00
39.34
+0.59
(+1.52%)
Pre-Market: 20:00
Azenta Net Income (Quarterly) : -1.529M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.529M |
| March 31, 2026 | -157.02M |
| December 31, 2025 | -5.19M |
| September 30, 2025 | 51.65M |
| June 30, 2025 | -0.332M |
| March 31, 2025 | -19.79M |
| December 31, 2024 | -7.073M |
| September 30, 2024 | -1.745M |
| June 30, 2024 | -0.158M |
| March 31, 2024 | -16.20M |
| December 31, 2023 | -7.192M |
| September 30, 2023 | 2.806M |
| June 30, 2023 | -2.463M |
| March 31, 2023 | -1.991M |
| December 31, 2022 | -11.24M |
| September 30, 2022 | -5.31M |
| June 30, 2022 | -7.015M |
| March 31, 2022 | -1.816M |
| December 31, 2021 | 2.858M |
| September 30, 2021 | -22.40M |
| June 30, 2021 | -1.842M |
| March 31, 2021 | -7.336M |
| December 31, 2020 | 2.706M |
| September 30, 2020 | -0.581M |
| June 30, 2020 | 13.70M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.192M |
| December 31, 2019 | 13.17M |
| September 30, 2019 | 5.532M |
| June 30, 2019 | 0.921M |
| March 31, 2019 | -2.829M |
| December 31, 2018 | 6.266M |
| September 30, 2018 | -1.212M |
| June 30, 2018 | 4.813M |
| March 31, 2018 | 62.50M |
| December 31, 2017 | 1.619M |
| September 30, 2017 | 17.39M |
| June 30, 2017 | 17.35M |
| March 31, 2017 | 14.00M |
| December 31, 2016 | 13.87M |
| September 30, 2016 | 10.55M |
| June 30, 2016 | 8.564M |
| March 31, 2016 | -83.94M |
| December 31, 2015 | -4.648M |
| September 30, 2015 | 6.563M |
| June 30, 2015 | 7.681M |
| March 31, 2015 | 2.711M |
| December 31, 2014 | -2.734M |
| September 30, 2014 | 0.262M |
| June 30, 2014 | -2.764M |
| March 31, 2014 | 2.103M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | -6.156M |
| Repligen Corp. | 5.008M |
| Bio-Techne Corp. | 54.64M |
| Codexis, Inc. | -12.00M |
| MetaStat, Inc. | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 161.18M |
| Total Expenses (Quarterly) | 162.71M |
| EPS Diluted (Quarterly) | 0.0542 |
| Enterprise Value | 1.422B |
| Gross Profit Margin (Quarterly) | 44.89% |
| Profit Margin (Quarterly) | -0.95% |
| Earnings Yield | -6.88% |
| Normalized Earnings Yield | -0.6217 |